222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details

臨床試験数 : 310 / 薬物数 : 295 - (DrugBank : 117) / 標的遺伝子数 : 63 - 標的パスウェイ数 : 194

13 trials found

diseases per page:

Showing 1 to 10 of 13 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05398653 (ClinicalTrials.gov)	February 24, 2022	26/5/2022	A Clinical Study of MIL62 in Primary Membranous Nephropathy	A Multicenter, Randomized, Controlled, Open Phase Ib/ ? Study Evaluating the Efficacy and Safety of ...	Primary Membranous Nephropathy	Drug: MIL62;Drug: Cyclosporine	Beijing Mabworks Biotech Co., Ltd.	NULL	Recruiting	18 Years	N/A	All	120	Phase 1/Phase 2	China
2	NCT04743739 (ClinicalTrials.gov)	April 14, 2021	30/1/2021	Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN	A Multicenter Randomized Controlled Trial of Rituximab Combined With Cyclosporine Versus Rituximab A ...	Idiopathic Membranous Nephropathy	Drug: Rituximab;Drug: cyclosporine	Peking Union Medical College Hospital	Beijing Tongren Hospital;Chinese Academy of Medical Sciences, Fuwai Hospital;The Luhe Teaching Hospi ...	Recruiting	18 Years	80 Years	All	126	Phase 3	China
3	NCT03170323 (ClinicalTrials.gov)	July 1, 2018	26/5/2017	Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membrano ...	A Prospective Randomized, Controlled Trial of Mycophenolate Mofetil Plus Steroid in the Treatment Of ...	Idiopathic Membranous Nephropathy	Drug: Mycophenolate Mofetil;Drug: Cyclosporins	Guangdong Provincial People's Hospital	NULL	Recruiting	18 Years	N/A	All	128	Phase 4	China
4	NCT03180723 (ClinicalTrials.gov)	July 1, 2017	3/6/2017	Effect of Rituximab in Treatment of Membranoproliferative Glomerulonephritis	Effect of Rituximab in Treatment of Primary Membranoproliferative Glomerulonephritis	Membranoproliferative Glomerulonephritis	Drug: Rituximab;Drug: Cyclosporin	Assiut University	NULL	Not yet recruiting	18 Years	N/A	All	30	Phase 3	NULL
5	NCT02173106 (ClinicalTrials.gov)	June 2014	23/6/2014	A Controlled Study of Steroids Plus CyclosporinTherapy for Patients of Idiopathic Membranous Nephrop ...	Opportunity, Validity and Security of Steroids Plus CyclosporinTherapy for Patients of Idiopathic Me ...	Idiopathic Membranous Nephropathy;Proteinuria;Spontaneous Remission;Steroid Nephropathy;CyclosporinO ...	Drug: steroid & Cyclosporin	Sun Yat-sen University	NULL	Recruiting	14 Years	75 Years	Both	180	Phase 2	China
6	NCT01180036 (ClinicalTrials.gov)	November 2011	10/8/2010	MEmbranous Nephropathy Trial Of Rituximab	A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membra ...	Idiopathic Membranous Nephropathy	Drug: Rituximab;Drug: Cyclosporine	Mayo Clinic	Columbia University;University of British Columbia;Ohio State University;Stanford University;Univers ...	Completed	18 Years	80 Years	All	130	Phase 2/Phase 3	United States;Canada
7	NCT01282073 (ClinicalTrials.gov)	March 2011	19/1/2011	Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy	A Randomized Controlled Multi-center Trial of Mycophenolate Mofetil for the Patient With High Risk M ...	Glomerulonephritis, Membranous	Drug: Mycophenolate mofetil , low dose steroid;Drug: Cyclosporin , low dose steroid	Kyungpook National University	Hanmi Pharmaceutical Company Limited	Recruiting	18 Years	N/A	Both	62	Phase 3	Korea, Republic of
8	NCT00977977 (ClinicalTrials.gov)	December 22, 2010	15/9/2009	Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy	Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy	Nephrotic Syndrome;Proteinuria;Autoimmune Disease;Glomerular Disease;Membranous Glomerulonephritis	Drug: Rituximab Infusion;Drug: Oral Cyclosporine	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	NULL	Recruiting	18 Years	N/A	All	30	Phase 2	United States
9	JPRN-UMIN000000963	2007/10/01	01/01/2010	Efficacy and safety of cyclosporine and steroid for the treatment of minimal change nephrotic syndro ...	Efficacy and safety of cyclosporine and steroid for the treatment of minimal change nephrotic syndro ...	Minimal change nephrotic syndrome	administration of cyclosporine	Yoshihiko Saito	NULL	Complete: follow-up complete	20years-old	75years-old	Male and Female	30	Not applicable	Japan
10	JPRN-UMIN000000621	2007/03/01	28/02/2007	Okayama nephrotic syndrome treatment group: Study group for short-term combination therapy of angiot ...	Okayama nephrotic syndrome treatment group: Study group for short-term combination therapy of angiot ...	Minimal change nephrotic syndrome	Prednisolone (+), combination therapy (-) Prednisolone (+), combination therapy (+)	Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentist ...	NULL	Complete: follow-up complete	16years-old	Not applicable	Male and Female	50	Not selected	Japan

First Previous1 2Next Last